|
Volumn 5, Issue 5, 1997, Pages 414-416
|
Mitomycin C and Vinblastine in combination with Amifostine in metastatic breast cancer. A feasibility study of the EORTC - Investigational Drug Branch for Breast Cancer (IDBBC)
|
Author keywords
Amifostine; Metastatic breast cancer; Mitomycin C vinblastine combination
|
Indexed keywords
AMIFOSTINE;
DEFIBROTIDE;
DEXAMETHASONE;
HALOPERIDOL;
METOCLOPRAMIDE;
MITOMYCIN C;
VINBLASTINE;
ADULT;
AGED;
ARTICLE;
BLOOD TOXICITY;
BREAST CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
FATIGUE;
FEASIBILITY STUDY;
GASTROINTESTINAL TOXICITY;
HUMAN;
HYPOTENSION;
INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
METASTASIS;
NEPHROTOXICITY;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
ADULT;
AGED;
AMIFOSTINE;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
FEASIBILITY STUDIES;
FEMALE;
HEMATOLOGIC DISEASES;
HUMANS;
LIVER NEOPLASMS;
MIDDLE AGED;
MITOMYCIN;
NEOPLASM METASTASIS;
PILOT PROJECTS;
PROSPECTIVE STUDIES;
RADIATION-PROTECTIVE AGENTS;
TREATMENT OUTCOME;
VINBLASTINE;
|
EID: 0030779045
PISSN: 09414355
EISSN: None
Source Type: Journal
DOI: 10.1007/s005200050101 Document Type: Article |
Times cited : (7)
|
References (8)
|